We have purchased 14.6 million treatment courses of oseltamivir, which is enough to treat 25 per cent. of the population. Our stockpile was completed in September.
Consideration is being given to increasing our antiviral stockpile, including purchasing alternative antivirals. In particular, we are looking at Relenza as a possible back up to Tamiflu.
We are currently looking at Relenza as a possible back up to Tamiflu.
The only other antiviral available is amantadine. We are not currently planning to purchase this, but our antiviral strategy remains under review.
The current version of the Department’s United Kingdom influenza pandemic contingency plan was published in October 2005. The plan describes the likely impact of an influenza pandemic for the UK and outlines the actions the Government and other authorities are taking to prepare for a possible pandemic, to slow down the spread of infection, minimise the health impact and minimise disruption to society.
The plan is currently being revised. The new version will have a broader scope than just the health response and cover wider areas of national planning. It is due to be published for comment on the Department’s website in early January.
The plan and further detailed information regarding our preparedness are available in the Library and on the Department's website at:
www.dh.gov.uk/pandemicflu.